Apogee Therapeutics, Inc. APGE Quick ratio
Quick ratio at other companies
Other financials
Where this comes from
Calculated from Apogee Therapeutics, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Apogee Therapeutics, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Apogee Therapeutics, Inc.'s quick ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Apogee Therapeutics, Inc.'s quick ratio?
- Apogee Therapeutics, Inc. (APGE) reported quick ratio of 32.6× in Q1 2026.
- How has Apogee Therapeutics, Inc.'s quick ratio changed year-over-year?
- Apogee Therapeutics, Inc.'s quick ratio increased by 105.9% year-over-year, from 15.8× to 32.6×.
- What is the long-term trend for Apogee Therapeutics, Inc.'s quick ratio?
- Over 3 years (2022 to 2025), Apogee Therapeutics, Inc.'s quick ratio has grown at a 20.4% compound annual growth rate (CAGR), from 15.2× to 26.6×.
- What does quick ratio mean?
- Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.